{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T18:29:08Z","timestamp":1792348148076,"version":"4.4.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000805","name":"ECDC","doi-asserted-by":"publisher","award":["ECDC\/2021\/019"],"award-info":[{"award-number":["ECDC\/2021\/019"]}],"id":[{"id":"10.13039\/501100000805","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.vaccine.2024.05.067","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T11:36:34Z","timestamp":1717500994000},"page":"3931-3937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023\u2013January 2024"],"prefix":"10.1016","volume":"42","author":[{"given":"Charlotte","family":"Laniece Delaunay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryse","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Maurel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Mazagatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luise","family":"Goerlitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrix","family":"Oroszi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"S\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Mart\u00ednez-Baz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Mlinari\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Latorre-Margalef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Laz\u0103r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"P\u00e9rez-Gimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"D\u00fcrrwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerg\u0151","family":"T\u00fari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne","family":"Rameix-Welti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Guiomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Castilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00ebtte","family":"Hooiveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Kure\u010di\u0107 Filipovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove","family":"Samuelsson Hagey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederika","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Ramos Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlena","family":"Kaczmarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7188-8404","authenticated-orcid":false,"given":"Esther","family":"Kissling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.05.067_b0005","unstructured":"European Medicines Agency. COVID-19 vaccines: authorised [Internet]. [cited 2024 Mar 21]. Available from: https:\/\/www.ema.europa.eu\/en\/human-regulatory\/overview\/public-health-threats\/coronavirus-disease-covid-19\/treatments-vaccines\/vaccines-covid-19\/covid-19-vaccines-authorised#covid-19-vaccines:-strains,-use-and-age-ranges-(new)-section."},{"key":"10.1016\/j.vaccine.2024.05.067_b0010","unstructured":"European Centre for Disease Prevention and Control. EMA and ECDC statement on updating COVID-19 vaccines to target new SARS-CoV-2 virus variants [Internet]. [cited 2024 Feb 12]. Available from: file:\/\/\/C:\/Users\/esthe\/Downloads\/ecdc-ema_statement_on_updating_covid-19_vaccines_composition_for_new_sars-cov-2_virus_variants_en(1).pdf."},{"key":"10.1016\/j.vaccine.2024.05.067_b0015","unstructured":"European Centre for Disease Prevention and Control. Interim COVID-19 vaccination coverage in the EU\/EEA during the 2023\u201324 season campaigns [Internet]. 2024 Jan [cited 2024 Apr 19]. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/interim-vaccine-overage-eu-eea-2023-24.pdf."},{"key":"10.1016\/j.vaccine.2024.05.067_b0020","unstructured":"European Centre for Disease Prevention and Control. European Respiratory Virus Surveillance Summary (ERVISS), 2024, Week 07. [Internet]. 202Available from: https:\/\/erviss.org\/."},{"issue":"39","key":"10.1016\/j.vaccine.2024.05.067_b0025","article-title":"I-MOVE study team. I-MOVE: a European network to measure the effectiveness of influenza vaccines","volume":"17","author":"Valenciano","year":"2012","journal-title":"Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull"},{"key":"10.1016\/j.vaccine.2024.05.067_b0030","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13069","article-title":"Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021\u20132022 I-MOVE primary care multicentre study","author":"Kissling","year":"2023","journal-title":"Influenza Other Respir Viruses [Internet]"},{"key":"10.1016\/j.vaccine.2024.05.067_b0035","unstructured":"European Centre for Disease Prevention and Control. Core protocol for ECDC studies of vaccine effectiveness against symptomatic laboratory-confirmed influenza or SARS-CoV-2 infection at primary care level: version 1.0, September 2023. [Internet]. LU: Publications Office; 2023 [cited 2024 Jan 26]. Available from: https:\/\/data.europa.eu\/doi\/10.2900\/25966."},{"issue":"12","key":"10.1016\/j.vaccine.2024.05.067_b0040","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2024.05.067_b0045","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciac234","article-title":"Effects of confounding bias in COVID-19 and influenza vaccine effectiveness test-negative designs due to correlated influenza and COVID-19 vaccination behaviors","author":"Doll","year":"2022","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"47","key":"10.1016\/j.vaccine.2024.05.067_b0050","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1016\/j.vaccine.2023.10.051","article-title":"Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86","volume":"41","author":"Lasrado","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.067_b0055","unstructured":"Nextstrain. Genomic epidemiology of novel coronavirus - Europe-focused subsampling [Internet]. [cited 2021 Oct 30]. Available from: https:\/\/nextstrain.org\/ncov\/gisaid\/europe."},{"issue":"2","key":"10.1016\/j.vaccine.2024.05.067_b0060","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/S1473-3099(23)00744-2","article-title":"Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure","volume":"24","author":"Yang","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.067_b0065","unstructured":"World Health Organization. Updated Risk Evaluation of JN.1, 09 January 2023 [Internet]. [cited 2024 May 16]. Available from: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/09022024_jn.1_ure.pdf?sfvrsn=a153518c_3."},{"key":"10.1016\/j.vaccine.2024.05.067_b0070","doi-asserted-by":"crossref","unstructured":"Link-Gelles R, Ciesla AA, Mak J, Miller JD, Silk BJ, Lambrou AS, et al. Early Estimates of Updated 2023\u20132024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults \u2014 Increasing Community Access to Testing Program, United States, September 2023\u2013January 2024. MMWR Morb Mortal Wkly Rep. 2024 Feb 1;73(4):77\u201383.","DOI":"10.15585\/mmwr.mm7304a2"},{"key":"10.1016\/j.vaccine.2024.05.067_b0075","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.7.2400076","article-title":"2023\/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)","author":"Skowronski","year":"2024","journal-title":"Eurosurveillance [Internet]"},{"key":"10.1016\/j.vaccine.2024.05.067_b0080","unstructured":"Laniece Delaunay C, Mazagatos C, Mart\u00ednez-Baz I, T\u00fari G, Goerlitz L, Meijer A, et al. Effectiveness of COVID-19 vaccines administered in autumn and winter 2022\/2023 in Europe. Submitt JAMA Netw Open."},{"issue":"12","key":"10.1016\/j.vaccine.2024.05.067_b0085","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S2213-2600(23)00306-5","article-title":"Effectiveness of BNT162b2 BA.4\/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case\u2013control study","volume":"11","author":"Tartof","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2024.05.067_b0090","article-title":"Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022\u2013May 2023","author":"Plumb","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.067_b0095","article-title":"XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against emerging SARS-CoV-2 variants [Internet]","author":"Wang","year":"2023","journal-title":"Immunology"},{"issue":"17","key":"10.1016\/j.vaccine.2024.05.067_b0100","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.vaccine.2013.02.053","article-title":"The test-negative design for estimating influenza vaccine effectiveness","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2024.05.067_b0105","first-page":"23435","author":"Powell","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2024.05.067_b0110","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/bmjebm-2021-111901","article-title":"Factors influencing estimated effectiveness of COVID-19 vaccines in non-randomised studies","volume":"27","author":"Ioannidis","year":"2022","journal-title":"BMJ Evid-Based Med"}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2024.06.056","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24006443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24006443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T10:23:13Z","timestamp":1728642193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24006443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":22,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0264410X24006443"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.067","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.vaccine.2024.06.056","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023\u2013January 2024","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}